Patent Assignment
Reel/Frame 025714/0331
Security Agreement
Recorded: 2011-01-28
Pages: 7
Assignors
COMPREHENSIVE NEUROSCIENCE, INC.
Executed: 2011-01-24
CARE MANAGEMENT TECHNOLOGIES, INC.
Executed: 2011-01-24
Assignee
OXFORD FINANCE CORPORATION, AS AGENT
133 NORTH FAIRFAX CORPORATION, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(3)
System and method for targeted interventions of physician prescription practices based on deviations from expert guidelines
Application:
09/968,726 →
Publication:
US 2002/0143579
Augmentation of Atypical Antipsychotic Agent Pharmacotherapy with Chromium Supplementation
Augmentation of Atypical Antipsychotic Agent Pharmacotherapy with Chromium Supplementation
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 31, 2001
From: DOCHERTY, JOHN P.
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 012410/0726 →
Assignment of Assignor's Interest
Apr 2, 2002
From: SURLES, RICHARD; CARPENTER, DANIEL
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 012747/0814 →
Assignment of Assignor's Interest
Aug 23, 2002
From: DOCHERTY, JOHN
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 013224/0519 →
Assignment of Assignor's Interest
Jan 5, 2005
From: DOCHERTY, JOHN
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 015540/0426 →
Assignment of Assignor's Interest
Apr 23, 2009
From: COMPREHENSIVE NEUROSCIENCE INC.
To: CARE MANAGEMENT TECHNOLOGIES, LLC
Reel/Frame 022588/0838 →
Release of Security Interest
Oct 26, 2011
From: OXFORD FINANCE LLC (SUCCESSOR IN INTEREST TO OXFORD FINANCE CORPORATION), AS AGENT
To: COMPREHENSIVE CLINICAL DEVELOPMENT, INC. (FKA COMPREHENSIVE NEUROSCIENCE, INC.); CASE MANAGEMENT TECHNOLOGIES, INC.
Reel/Frame 027123/0970 →
Corrective Assignment to Correct the Typographical Error in the Assignee Name - Case Management Technologies, Inc. Previously Recorded on Reel 027123 Frame 0970. Assignor(S) Hereby Confirms the Assignee Name Should Be Care Management Technologies, Inc..
Oct 27, 2011
From: OXFORD FINANCE LLC (SUCCESSOR IN INTEREST TO OXFORD FINANCE CORPORATION), AS AGENT
To: COMPREHENSIVE CLINICAL DEVELOPMENT, INC. (FKA COMPREHENSIVE NEUROSCIENCE, INC.); CARE MANAGEMENT TECHNOLOGIES, INC.
Reel/Frame 027133/0506 →